BiopharmaTrend.com

MaaT Pharma

MaaT Pharma

Private company
MAAT PHARMA

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat serious diseases linked to imbalances in the intestinal microbiome. It has developed the first treatment solution based on autologous microbiotherapy. MaaT Pharma envisages a first therapeutic application for patients suffering from leukaemia and bone & joint infections, whose major treatment contributes to dysbiosis. Funded jointly by a team which brings together world-class medical-scientific and entrepreneurial skills, MaaT Pharma has the ambition of becoming a leader in microbiome protection and the treatment of dysbiosis.


Founded
2014
Status
Private company
Geography
France based
Funding
$20 M
Patents
8
Research papers
4
Clinical Trials
5

Products

No products posted yet

Services

No services posted yet


This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page